An <i>MGRN1</i>-Based Biomarker Combination Accurately Predicts Melanoma Patient Survival.

导出 OA

翻译打印收藏纠错

第一作者： José,Sánchez-Beltrán

第一单位： Department of Biochemistry, Molecular Biology and Immunology, School of Medicine, Campus de Excelencia Internacional Regional (CEIR), Campus Mare Nostrum (CMN), University of Murcia, 30120 Murcia, Spain.;Biomedical Research Institute of Murcia (Instituto Murciano de Investigación Biosanitaria, IMIB), 30120 Murcia, Spain.

作者： José,Sánchez-Beltrán ^[1] ; Javier,Soler Díaz ^[2] ; Cecilia,Herraiz ^[1] ; Conchi,Olivares ^[1] ; Sonia,Cerdido ^[1] ; Pablo,Cerezuela-Fuentes ^[3] ; José Carlos,García-Borrón ^[1] ; Celia,Jiménez-Cervantes ^[1]

作者单位： Department of Biochemistry, Molecular Biology and Immunology, School of Medicine, Campus de Excelencia Internacional Regional (CEIR), Campus Mare Nostrum (CMN), University of Murcia, 30120 Murcia, Spain.;Biomedical Research Institute of Murcia (Instituto Murciano de Investigación Biosanitaria, IMIB), 30120 Murcia, Spain. ^[1] Department of Biochemistry, Molecular Biology and Immunology, School of Medicine, Campus de Excelencia Internacional Regional (CEIR), Campus Mare Nostrum (CMN), University of Murcia, 30120 Murcia, Spain. ^[2] Biomedical Research Institute of Murcia (Instituto Murciano de Investigación Biosanitaria, IMIB), 30120 Murcia, Spain.;Medical Oncology Department, Hospital Clínico Universitario Virgen de La Arrixaca, 30120 Murcia, Spain. ^[3]

关键词 MGRN1 MLANA PMEL TNM staging TYRP1 gene enrichment analysis melanoma prognostic biomarkers survival